Rotavirus vaccines have been reported to cause enteropathy in infants who received vaccine prior to a diagnosis of SCID.
We studied the impact of rotavirus vaccine on transplant outcome in 24 infants with SCID transplanted at the Great North Children’s Hospital between 2013 and 2018.
7 patients diagnosed at birth did not receive rotavirus vaccine. Rotavirus vaccine was associated with increased incidence of acute GvHD (p=0.03), increased need of PN (p=0.01) and increased need for ICU (p=0.03).
No rotavirus vaccine | rotavirus vaccine | p-value | |
Number | 12 | 12 | |
Median age at diagnosis (range), months | 0.6(birth–13.6) | 4.6(2.8-7.1) | 0.005 |
Median age at transplant (range), months | 2.4(1.0 – 15.4) | 7.4(3.4-9.4) | 0.005 |
Median interval transplant to diagnosis (range), months | 1.9(0.24– 2.6) | 1.6(0.6-4.1) | 0.64 |
BCG vaccination, n | 4 | 1 | 0.16 |
PCP, n | 0 | 6 | 0.01 |
Growth failure, n | 3 | 6 | 0.4 |
Conditioned transplant, n (%) | 11(92) | 10(83) | 0.5 |
MFD | 5(42) | 3(25) | |
MUD | 4(22) | 4(33) | |
Haploidentical | 3(25) | 4(42) | |
Stem cell | 0.80 | ||
Marrow | 5 | 3 | |
PBSC | 1 | 1 | |
TCR ab/CD19 PBSC | 2 | 3 | |
CB | 3 | 5 | |
Median TNC (range), 108/kg | 11.5(0.93-40.0) | 9.65(0.21-53.0) | 0.45 |
Median CD34 (range), 106/kg | 11.3(1.9-96.0) | 0.4(0.5-26.6) | 0.98 |
aGvHD, n | 0 | 4 | 0.03 |
PN, n | 3 | 9 | 0.01 |
Median days of PN (range) | 36(26-125) | 87(21-196) | 0.31 |
PICU admission, n | 1 | 6 | 0.03 |
Median days of PICU stay (range) | 0(0-39) | 16(0-25) | 0.05 |
Median days of total inpatient stay (range) | 83.5(0-168) | 129.5(26-341) | 0.13 |
Rotavirus vaccine is associated with significant transplant morbidity for infants with SCID